Back to News
Market Impact: 0.4
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair
Source: benzinga.com
M&A & RestructuringHealthcare & BiotechMedical Devices
Axogen agreed to acquire privately held medical-device manufacturer BioCircuit Technologies for $200 million in cash. The transaction expands Axogen's medical-device footprint, though the article provides no details on financing, expected synergies, or closing timing.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
AXGN0.65
More News
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Braskem creditors, shareholders near deal on $11bn debt restructuring
- Instacart reportedly discussed selling itself with DoorDash and Uber
- IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
- ‘There’s nothing temporary about a temporary store’: How Spirit Halloween’s CEO took it from 130 stores to 1,550—and swallowed your mall’s Hot Topic
- J&J prostate cancer drug shows promising tumor responses in early trial